Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a phase 3 trial of its sickle cell disease (SCD) therapy mitapivat, sending ...

French pharmaceutical company Servier has swooped on Agios Pharma’s marketed and experimental cancer drugs, buying the entire franchise in a deal that leaves the US biopharma focused on genetic ...

CAMBRIDGE, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients ...

Understand the cash flow statement for Agios Pharmaceuticals, Inc. (AGIO), learn where the money comes from and how the company spends it.

The new indication is relatively rare in the U.S., but pricing is substantial, and the need for the treatment is significant. The positive update turns the company's fortunes around after a ...

Get the detailed quarterly/annual income statement for Agios Pharmaceuticals, Inc. (AGIO). Find out the revenue, expenses and profit or loss over the last fiscal year.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Agios Dionysios was born on the Greek island of Zakynthos in 1546. His ancestry is traced back through the Venetian conquerors in a family tree whose roots lay in part in Italy and in part in Normandy ...